Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 4 |
2023 | 4 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
New treatment options for nonsurgical management of uterine fibroids.
Curr Opin Obstet Gynecol. 2023 Aug 1;35(4):288-293. doi: 10.1097/GCO.0000000000000880. Epub 2023 May 3.
Curr Opin Obstet Gynecol. 2023.
PMID: 37144584
Review.
Oral Gonadotropin-Releasing Hormone Antagonists for the Treatment of Uterine Leiomyomas.
Neblett MF 2nd, Stewart EA.
Neblett MF 2nd, et al.
Obstet Gynecol. 2023 May 1;141(5):901-910. doi: 10.1097/AOG.0000000000005145. Epub 2023 Apr 5.
Obstet Gynecol. 2023.
PMID: 37103532
Item in Clipboard
Frequency and type of premature or early menopause in a geographically defined American population.
Rocca WA, Gazzuola Rocca L, Smith CY, Kapoor E, Faubion SS, Stewart EA.
Rocca WA, et al.
Maturitas. 2023 Apr;170:22-30. doi: 10.1016/j.maturitas.2023.01.012. Epub 2023 Feb 6.
Maturitas. 2023.
PMID: 36753871
Free PMC article.
Item in Clipboard
Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials.
Stewart EA, Lukes AS, Venturella R, Li Y, Hunsche E, Wagman RB, Al-Hendy A.
Stewart EA, et al.
Am J Obstet Gynecol. 2023 Mar;228(3):320.e1-320.e11. doi: 10.1016/j.ajog.2022.11.1278. Epub 2022 Nov 9.
Am J Obstet Gynecol. 2023.
PMID: 36370871
Free article.
Clinical Trial.
Item in Clipboard
Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas.
Al-Hendy A, Lukes AS, Poindexter AN 3rd, Venturella R, Villarroel C, McKain L, Li Y, Wagman RB, Stewart EA.
Al-Hendy A, et al.
Obstet Gynecol. 2022 Dec 1;140(6):920-930. doi: 10.1097/AOG.0000000000004988. Epub 2022 Nov 2.
Obstet Gynecol. 2022.
PMID: 36357960
Free PMC article.
Clinical Trial.
Item in Clipboard
Loss of the repressor REST affects progesterone receptor function and promotes uterine leiomyoma pathogenesis.
Cloud AS, Koohestani F, McWilliams MM, Ganeshkumar S, Gunewardena S, Graham A, Nothnick WB, Chennathukuzhi VM.
Cloud AS, et al.
Proc Natl Acad Sci U S A. 2022 Nov;119(44):e2205524119. doi: 10.1073/pnas.2205524119. Epub 2022 Oct 25.
Proc Natl Acad Sci U S A. 2022.
PMID: 36282915
Free PMC article.
Item in Clipboard
Loss of REST in breast cancer promotes tumor progression through estrogen sensitization, MMP24 and CEMIP overexpression.
Cloud AS, Vargheese AM, Gunewardena S, Shimak RM, Ganeshkumar S, Kumaraswamy E, Jensen RA, Chennathukuzhi VM.
Cloud AS, et al.
BMC Cancer. 2022 Feb 17;22(1):180. doi: 10.1186/s12885-022-09280-2.
BMC Cancer. 2022.
PMID: 35177031
Free PMC article.
Item in Clipboard
Cite
Cite